Reliability of Ki67‐Labeling Index in Core Needle Biopsy Specimens of ER+/HER2− Breast Cancers
Pathology International · 2025
DOI: 10.1111/pin.70005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, 2025. Verfasst von Yumi Fukaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of General Thoracic Surgery and Breast and Endocrine Surgery, Yonago, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Ki-67 Antigen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
The reliability of Ki67‐labeling index (LI) in core needle biopsy (CNB) of ER+/HER2− invasive breast carcinoma (IBC) and factors affecting the discordance of Ki67‐LI between CNB and surgical resection (SR) remain unsolved. We aimed to elucidate factors influencing the discordance of Ki67‐LI between CNB and SR to classify ER+/HER2− IBC into luminal A‐like (LumA) and luminal B‐like (LumB). The cohort included 326 ER+/HER2− IBCs available with Ki67‐LI data at both CNB and SR specimens. Survival analysis was performed on 122 patients. Spearman's rank correlation coefficient of Ki67‐LI between them was 0.683. The log‐rank test showed that patients with ER+/HER2− IBC with ≥ 20% Ki67‐LI at CNB ( p < 0.001) and SR specimens ( p < 0.001) had significantly shorter disease‐free survival. In multivariate analysis, a negative PgR ( p = 0.002) and > 2 cm pathological tumor size ( p < 0.001) had the most significant effect on the discordance of Ki67‐LI between CNB and SR at 20% and 30% cutoffs, respectively. Histological grade III had a significant effect on the concordance between them ( p = 0.01) at 20% cutoff. Ki67‐LI assessment in CNB may be useful for classifying ER+/HER2− IBC into LumA and LumB with caution of some prognostic factors and cutoffs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of General Thoracic Surgery and Breast and Endocrine Surgery, Yonago, Japan.
- Department of Pathology, Faculty of Medicine, Tottori University, Tottori, Japan.
Zitieren
APA
Fukaya, Y., Wakahara, M., Hosoya, K., Nouchi, N., & Umekita, Y. (2025). Reliability of Ki67‐Labeling Index in Core Needle Biopsy Specimens of ER+/HER2− Breast Cancers. Pathology International. https://doi.org/10.1111/pin.70005
Vancouver
Fukaya Y, Wakahara M, Hosoya K, Nouchi N, Umekita Y. Reliability of Ki67‐Labeling Index in Core Needle Biopsy Specimens of ER+/HER2− Breast Cancers. Pathology International. 2025. doi:10.1111/pin.70005
BibTeX
@article{Fukaya2025,
author = {Fukaya, Yumi and Wakahara, Makoto and Hosoya, Keiko and Nouchi, Naoko and Umekita, Yoshihisa},
title = {Reliability of Ki67‐Labeling Index in Core Needle Biopsy Specimens of ER+/HER2− Breast Cancers},
journal = {Pathology International},
year = {2025},
doi = {10.1111/pin.70005}
}
EUVIMED